Commentary · 31 Dec 2025
Mini reviewPublished 28 Jun 2024
Discovery of New Autotaxin Inhibitors Using Structure-based Approaches
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The discovery of effective AutoTaXin (ATX) inhibitors is crucial for developing therapies targeting various diseases, including cancer, inflammation and fibrosis. Structure-based drug design has emerged as a powerful strategy to identify and optimize ATX inhibitors with enhanced potency and selectivity. This comprehensive review explores recent advancements in structure-based approaches for discovering ATX inhibitors, encompassing computational modeling, structural biology insights and medicinal chemistry strategies. Key findings highlight successful examples of ATX inhibitor development, including structure-activity relationship studies and mechanism-based drug design. The review discusses challenges, opportunities and future directions in leveraging structure-based approaches to accelerate the discovery of next-generation ATX inhibitors for clinical applications.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Research.
Commentary · 31 Dec 2025
Vitamin C and Common Cold: Prevention Lacks Evidence
Brief report · 31 Dec 2025
New Antihypertensive Patch: Efficacy, Safety, and Adherence
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Research
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Meihui Nelson”
